1489-03-8 Usage
General Description
"S-Triazolo[1,5-a]-s-triazin-7(6H)-one" is a chemical compound with a unique three-ring structure, consisting of two fused 1,2,4-triazole rings and one s-triazine ring. It is a heterocyclic compound that has shown potential biological activity, particularly as a nitrogen-based heterocycle. s-Triazolo[1,5-a]-s-triazin-7(6H)-one has been studied for its potential as an anticancer agent, with research indicating its effects against various cancer cell lines. Additionally, "s-Triazolo[1,5-a]-s-triazin-7(6H)-one" has also been explored for its potential as a reducing agent and for its role in organic synthesis. Overall, this compound is of interest due to its unique structure and potential biological and synthetic applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1489-03-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,4,8 and 9 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1489-03:
(6*1)+(5*4)+(4*8)+(3*9)+(2*0)+(1*3)=88
88 % 10 = 8
So 1489-03-8 is a valid CAS Registry Number.
InChI:InChI=1/C4H3N5O/c10-4-7-1-5-3-6-2-8-9(3)4/h1-2H,(H,5,6,7,8,10)
1489-03-8Relevant articles and documents
Synthesis and pharmacological activity of triazolo[1,5-α]triazine derivatives inhibiting eosinophilia
Akahoshi, Fumihiko,Takeda, Shinji,Okada, Takehiro,Kajii, Masahiko,Nishimura, Hiroko,Sugiura, Masanori,Inoue, Yoshihisa,Fukaya, Chikara,Naito, Youichiro,Imagawa, Takashi,Nakamura, Norifumi
, p. 2985 - 2993 (2007/10/03)
In continuation of our previous work on eosinophilia inhibitors, we synthesized an additional series of inhibitors, which consisted of 5-amino- 1-[(methylamino)thiocarbonyl]-1H-1,2,4-triazole derivatives and a newly developed series of 1,2,4-triazolo[1,5-